International Journal of Gynecological Cancer,
Journal Year:
2023,
Volume and Issue:
34(5), P. 760 - 772
Published: Dec. 15, 2023
Platinum-resistant
ovarian
cancer
is
difficult
to
treat
and
has
a
poor
prognosis.
Patients
with
platinum-resistant
have
limited
treatment
options
often
benefit
from
existing
chemotherapeutic
agents.
There
lack
of
contemporary
effective
anticancer
drugs
reliable
predictive
biomarkers
for
this
aggressive
cancer.
Recent
cutting-edge
research
presented
at
the
2023
American
Society
Clinical
Oncology
(ASCO)
European
Medical
(ESMO)
Annual
Meetings
provided
insights
into
several
potential
therapeutic
targets,
such
as
DNA
damage
repair
proteins,
cell-cycle
regulators,
immune-modulating
In
addition,
antibody–drug
conjugates
new
practice-changing
results
in
Here,
we
review
annual
event,
focus
on
clinical
trials
investigating
novel
approaches
cancer,
addition
prognostic
optimal
patient
selection,
other
topics,
real-world
evidence.
Frontiers in Oncology,
Journal Year:
2023,
Volume and Issue:
13
Published: Sept. 8, 2023
Lung
cancer
(LC)
is
a
heterogeneous
disease
with
high
malignant
degree,
rapid
growth,
and
early
metastasis.
The
clinical
outcomes
of
LC
patients
are
generally
poor
due
to
the
insufficient
elucidation
pathological
mechanisms,
low
efficiency
detection
assessment
methods,
lack
individualized
therapeutic
strategies.
Non-coding
RNAs
(ncRNAs),
including
microRNA
(miRNA),
long
non-coding
RNA
(lncRNA),
circular
(circRNA),
endogenous
regulators
that
widely
involved
in
modulation
almost
all
aspects
life
activities,
from
organogenesis
aging
immunity
cancer.
They
commonly
play
vital
roles
various
biological
processes
by
regulating
gene
expression
via
their
interactions
DNA,
RNA,
or
protein.
An
increasing
amount
studies
have
demonstrated
ncRNAs
closely
correlated
initiation
development
LC.
Their
dysregulation
promotes
progression
distinct
such
as
influencing
protein
activity,
activating
oncogenic
signaling
pathways,
altering
specific
expression.
Furthermore,
some
present
certain
values
biomarker
candidates
targets
for
patients.
A
complete
understanding
mechanisms
may
be
highly
beneficial
developing
ncRNA-based
therapeutics
This
review
mainly
focuses
on
intricate
miRNA,
lncRNA,
circRNA
discuss
underlying
applications
treatment.
Theranostics,
Journal Year:
2023,
Volume and Issue:
14(1), P. 143 - 158
Published: Nov. 15, 2023
Human
osteogenic
differentiation
is
a
complex
and
well-orchestrated
process
which
involves
plethora
of
molecular
players
cellular
processes.A
growing
number
studies
have
underlined
that
circular
RNAs
(circRNAs)
play
an
important
regulatory
role
during
human
differentiation.CircRNAs
are
single-stranded,
covalently
closed
non-coding
RNA
molecules
acquiring
increased
attention
as
epigenetic
regulators
gene
expression.Given
their
intrinsic
high
conformational
stability,
abundance,
specificity,
circRNAs
can
undertake
various
biological
activities
in
order
to
regulate
multiple
processes,
including
differentiation.The
most
recent
evidence
indicates
control
osteogenesis
by
preventing
the
inhibitory
activity
miRNAs
on
downstream
target
genes,
using
competitive
endogenous
mechanism.The
aim
this
review
draw
currently
known
mechanisms
differentiation.Specifically,
we
provide
understanding
advances
research
conducted
mesenchymal
stem
cell
types
importance
regulating
osteogenesis.A
comprehensive
underlying
circRNA
will
improve
knowledge
processes
bone
growth,
resulting
potential
development
novel
preclinical
clinical
discovery
diagnostic
therapeutic
tools
for
disorders.
Seminars in Cancer Biology,
Journal Year:
2023,
Volume and Issue:
92, P. 74 - 83
Published: April 11, 2023
Cancer
'stemness'
is
fundamental
to
cancer
existence.
It
defines
the
ability
of
cells
indefinitely
perpetuate
as
well
differentiate.
stem
cell
populations
within
a
growing
tumor
also
help
evade
inhibitory
effects
chemo-
radiation-therapies,
in
addition
playing
an
important
role
metastases.
NF-κB
and
STAT-3
are
representative
transcription
factors
(TFs)
that
have
long
been
associated
with
stemness,
thus
presenting
attractive
targets
for
therapy.
The
interest
non-coding
RNAs
(ncRNAs)
recent
years
has
provided
further
insight
into
mechanisms
by
which
TFs
influence
characteristics.
There
evidence
direct
regulation
ncRNAs,
such
as,
microRNAs
(miRNAs),
(lncRNAs)
circular
(circRNAs),
vice
versa.
Additionally,
TF-ncRNAs
regulations
often
indirect,
involving
ncRNA-target
genes
or
sponging
other
ncRNA
species
individual
ncRNAs.
information
rapidly
evolving
this
review
provides
comprehensive
interactions
implications
on
stemness
response
therapies.
Such
knowledge
will
uncover
many
levels
tight
control
providing
novel
opportunities
therapy
process.
Molecular Biomedicine,
Journal Year:
2023,
Volume and Issue:
4(1)
Published: June 5, 2023
Abstract
The
tumor
microenvironment
(TME)
is
crucial
to
neoplastic
processes,
fostering
proliferation,
angiogenesis
and
metastasis.
Epigenetic
regulations,
primarily
including
DNA
RNA
methylation,
histone
modification
non-coding
RNA,
have
been
generally
recognized
as
an
essential
feature
of
malignancy,
exceedingly
contributing
the
dysregulation
core
gene
expression
in
cells,
bringing
about
evasion
immunosurveillance
by
influencing
immune
cells
TME.
Recently,
compelling
evidence
highlighted
that
clinical
therapeutic
approaches
based
on
epigenetic
machinery
modulate
carcinogenesis
through
targeting
TME
components,
normalizing
cells’
phenotype,
suppressing
neovascularization
repressing
immunosuppressive
components
Therefore,
nominated
a
promising
target
for
drugs
cancer
management.
This
review
focuses
mechanisms
modifications
occurring
pivotal
stroma,
myeloid
various
tumors
reported
last
five
years,
concludes
tight
correlation
between
reprogramming
progression
immunosuppression,
summarizes
current
advances
treatments
potential
targets
with
reference
drugs.
Finally,
we
summarize
some
restrictions
field
research
at
moment,
further
discuss
several
interesting
strategies
boost
antitumor
immunity.
Diagnostics,
Journal Year:
2023,
Volume and Issue:
13(18), P. 2888 - 2888
Published: Sept. 8, 2023
Diagnosing
brain
tumors,
especially
malignant
variants,
such
as
glioblastoma,
medulloblastoma,
or
metastasis,
presents
a
considerable
obstacle,
while
current
treatment
methods
often
yield
unsatisfactory
results.
The
monitoring
of
individuals
with
neoplasms
becomes
burdensome
due
to
the
intricate
tumor
nature
and
associated
risks
tissue
biopsies,
compounded
by
restricted
accuracy
sensitivity
presently
available
non-invasive
diagnostic
techniques.
uncertainties
surrounding
diagnosis
tumor’s
reaction
can
lead
delays
in
critical
determinations
that
profoundly
influence
prognosis
disease.
Consequently,
there
exists
pressing
necessity
formulate
validate
dependable,
minimally
invasive
biomarkers
effectively
diagnose
predict
tumors.
Cell-free
microRNAs
(miRNAs),
which
remain
stable
detectable
human
bodily
fluids,
blood
cerebrospinal
fluid
(CSF),
have
emerged
potential
indicators
for
range
ailments,
tumors
included.
Numerous
investigations
showcased
viability
profiling
cell-free
miRNA
expression
both
CSF
samples
obtained
from
patients
Distinct
miRNAs
demonstrate
varying
patterns
within
blood.
While
exhibit
diagnosing,
prognosticating,
across
diverse
types,
they
fall
short
diagnosing
Conversely,
profile
demonstrates
high
delivering
precise
specific
evaluations
Non-coding RNA Research,
Journal Year:
2023,
Volume and Issue:
9(1), P. 116 - 124
Published: Nov. 18, 2023
CC
(CC)
remains
a
significant
global
health
concern,
imposing
substantial
burden
on
women
worldwide
due
to
its
high
incidence
and
mortality
rates.
To
address
this
issue,
there
is
need
for
ongoing
research
uncover
the
underlying
molecular
mechanisms
of
discover
novel
diagnostic
therapeutic
strategies.
Recent
progress
in
non-coding
RNAs
(ncRNAs)
has
opened
new
avenues
investigation,
circular
(circRNAs)
have
emerged
as
molecules
with
diverse
roles
various
cellular
processes.
These
circRNAs
are
distinct
structure,
forming
closed
loop,
setting
them
apart
from
their
linear
counterparts.
They
intricately
involved
regulating
different
aspects
functions,
particularly
cell
growth
development.
Remarkably,
can
varying
either
promoting
or
inhibiting
oncogenic
processes,
depending
specific
context.
studies
identified
abnormal
expression
patterns
associated
CC,
indicating
involvement
disease
The
differing
profiles
linked
present
promising
opportunities
early
detection,
precise
prognosis
evaluation,
personalized
treatment
In
comprehensive
review,
we
embark
detailed
exploration
CC-related
circRNAs,
elucidating
providing
insights
into
intricate
governing
CC's
onset
progression.
A
growing
body
evidence
strongly
suggests
that
serve
valuable
biomarkers
detection
hold
potential
targets
intervention.
By
delving
complex
interplay
between
paving
way
innovative,
individualized
approaches
combat
serious
disease,
goal
reducing
impact
women's
globally
improving
patient
outcomes.
As
our
understanding
context
continues
deepen,
outlook
breakthroughs
diagnosis
becomes
increasingly
promising.
Non-coding RNA Research,
Journal Year:
2023,
Volume and Issue:
8(4), P. 686 - 692
Published: Oct. 12, 2023
Traumatic
brain
injury
(TBI)
is
a
complex
neurological
disorder
that
often
results
in
long-term
disabilities,
cognitive
impairments,
and
emotional
disturbances.
Despite
significant
advancements
understanding
the
pathophysiology
of
TBI,
effective
treatments
remain
limited.
In
recent
years,
exosomal
non-coding
RNAs
(ncRNAs)
have
emerged
as
potential
players
TBI
pathogenesis
novel
diagnostic
therapeutic
targets.
Exosomal
ncRNAs
are
small
RNA
molecules
secreted
by
cells
transported
to
distant
sites,
where
they
can
modulate
gene
expression
cell
signaling
pathways.
They
been
shown
play
important
roles
various
aspects
such
neuroinflammation,
blood-brain
barrier
dysfunction,
neuronal
apoptosis.
The
ability
cross
reach
parenchyma
makes
them
attractive
candidates
for
non-invasive
biomarkers
drug
delivery
systems.
However,
challenges
still
need
be
addressed
before
translated
into
clinical
practice,
including
standardization
isolation
quantification
methods,
validation
their
prognostic
value,
optimization
efficacy
safety.
This
review
aims
summarize
current
knowledge
regarding
role
biogenesis,
function,
applications
diagnosis,
prognosis,
treatment.
We
also
discuss
future
perspectives
using
tools
management.
Non-coding RNA Research,
Journal Year:
2023,
Volume and Issue:
8(3), P. 392 - 400
Published: May 26, 2023
Small
interfering
RNA
(siRNAs)
is
a
double-stranded
molecule
which
can
hybridize
with
specific
mRNA
sequence
and
block
the
translation
of
numerous
genes
to
regulate
endogenous
defend
genome
from
invasive
nucleic
acids.
The
use
siRNAs
has
been
studied
as
treatment
option
for
various
skin
conditions.
One
main
obstacles
in
dermal
or
transdermal
delivery
this
compound
low
permeability,
application
limited
by
its
negative
charge,
high
polarity,
susceptibility
degradation
nucleases,
difficulty
penetrating
barrier.
Effective
therapeutic
biomolecules
their
target
challenging
issue,
be
solved
innovations
drug
systems
lead
improvement
efficiency
many
new
biopharmaceuticals.
Designing
novel
garnered
tremendous
attention
both
cosmeceutical
pharmaceutical
research
industries,
offers
number
advantages.
Developing
safe
efficient
vectors
essential
effective
diseases.
In
recent
years,
significant
progress
made
creation
using
lipids,
polymers,
cell-penetrating
peptides,
nanoparticles
other
biologically
active
agents.
review
we
will
focus
on
advancements
vectors,
such
liposomes,
dendrimers,
spherical
acid
nanoparticles.
Non-Coding RNA,
Journal Year:
2024,
Volume and Issue:
10(5), P. 50 - 50
Published: Sept. 30, 2024
Introduction:
Lung
cancer
remains
one
of
the
most
prevalent
and
deadly
cancers
globally,
with
high
mortality
rates
largely
due
to
late-stage
diagnosis,
aggressive
progression,
frequent
recurrence.
Despite
advancements
in
diagnostic
techniques
therapeutic
interventions,
overall
prognosis
for
lung
patients
continues
be
dismal.
Method:
Emerging
research
has
identified
non-coding
RNAs
(ncRNAs),
including
microRNAs,
long
RNAs,
circular
as
critical
regulators
gene
expression,
significantly
influencing
biology.
These
ncRNAs
play
pivotal
roles
various
aspects
pathogenesis,
tumor
initiation,
metastasis,
resistance
therapy.
Results:
We
provide
a
comprehensive
analysis
current
understanding
cancer,
emphasizing
their
potential
biomarkers
early
prognostication,
prediction
response.
explore
biological
functions
ncRNAs,
involvement
key
oncogenic
pathways,
molecular
mechanisms
by
which
they
modulate
expression
cellular
processes
cancer.
Furthermore,
this
review
highlights
recent
advances
ncRNA-based
tools
strategies,
such
miRNA
mimics
inhibitors,
lncRNA-targeted
therapies,
circRNA-modulating
approaches,
offering
promising
avenues
personalized
medicine.
Conclusion:
Finally,
we
discuss
challenges
future
directions
ncRNA
research,
need
large-scale
validation
studies
development
efficient
delivery
systems
therapies.
This
underscores
revolutionize
management
providing
novel
options
that
could
improve
patient
outcomes.